DLB stock

Dolby Laboratories (DLB) support and resistance · P/E 28, rev $1.35B

Dolby Laboratories (DLB) is a specialty business services company listed on US.

This page maps Dolby Laboratories (DLB) support and resistance from cached range and valuation — not a live tape and not a trade alert.

Latest reported DLB revenue for 2025-09-26 was $1.35B. Net income was $256.5M. Revenue was up 5.9% from 2024-09-27 to 2025-09-26. DLB currently screens at market cap $7.19B and trailing P/E 28.3.

DLB currently screens at market cap $7.19B and trailing P/E 28.3. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.

A new DLB 8-K or 10-Q can move the levels that matter more than a drawing on a chart.

Not investment advice. Use the DLB quote page for the session range and the stock page for the full model.

Not investment advice.

Full DLB analysis